Metagenomi logo

Metagenomi

MGX | NASDAQ
Chart Builder DCF Calculator
$0.68
-$0.01 (-1.69%)
At close: Nov 16, 2026, 4:00 PM ET
$0.66
-$0.02 (-3.38%)
After-hours: Nov 16, 2026, 6:18 PM ET
-1.69%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
32
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #738/1021 (Top 72%)

Key Statistics

Market Data

Market Cap $25.71M
1D Range
0.66 0.71
52W Range
0.66 1.82

Valuation (TTM)

PE -0.27
PB 0.28
EV/EBITDA 0.44

Valuation (NTM)

Forward PE N/A
Forward PEG -0.10
Price Target $14.50
Loading financial charts...

Profile

Metagenomi, Inc. operates as a biotechnology company focused on gene editing, committed to developing therapeutic solutions for patients. The company utilizes a distinctive genome editing toolkit, sou...

Sector Healthcare
Industry Biotechnology
Employees 113
IPO Date Feb 9, 2024
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 10, 2026
EPS
-$0.56
Beat +12.43%
REV
$2.18M
Miss -15.18%
Next Earnings
Mar 4, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$14.50
Upside
+2032.35%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.